Nanjing Reju Therapeutics Co., Ltd
Clinical trials sponsored by Nanjing Reju Therapeutics Co., Ltd, explained in plain language.
-
New eye ointment for dry eye passes first safety check
Symptom relief Not yet recruitingThis early-stage study tests whether a new eye ointment called RC017 is safe and tolerable in 24 healthy adults aged 18 to 55. The ointment is being developed to treat dry eye disease. Participants will receive either the ointment or a placebo, and researchers will monitor for si…
Phase: PHASE1 • Sponsor: Nanjing Reju Therapeutics Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New inhaled drug for lung disease tested in healthy people first
Knowledge-focused Not yet recruitingThis early-stage study tests a new inhaled drug called RC010 in 42 healthy adults in China. The main goal is to check if it is safe and how the body processes it. This drug is being developed for a serious lung condition called idiopathic pulmonary fibrosis (IPF), but this study …
Phase: PHASE1 • Sponsor: Nanjing Reju Therapeutics Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC